EliseAI · 2 days ago
Enterprise Account Executive | Healthcare
EliseAI is a company focused on improving housing and healthcare through AI integration. They are seeking an Enterprise Account Executive to build a new business unit in healthcare, responsible for identifying and closing new business opportunities.
Artificial Intelligence (AI)Business IntelligenceMachine LearningProperty ManagementPropTechReal Estate
Responsibilities
Work with prospective C-Suite, VP, and Director level executives to drive EliseAI adoption in the healthcare industry
Own the entire sales cycle – prospecting, initial outreach, product demos, negotiations, and expansions
Attend industry conferences to increase market presence of EliseAI throughout the US
Act as a bridge between customers and product teams for new features and solutions
Build out playbooks, processes, scripts, etc. for the next stage of growth
Attract top-tier talent to join our driven team
Qualification
Required
3+ years quota carrying sales experience in SaaS preferably
Minimum annual quota of $1.2m of SaaS or net revenue in a quota carrying role
Demonstrated experience in consistently meeting and exceeding sales quotas
Experience in managing complex sales processes (multi-threading, procurement, etc.)
Willingness to work in person at our NYC office 5 days a week
Preferred
Experience as a top performer SDR a plus
Benefits
Equity in the company
Medical, Dental and Vision premiums covered at 100%
Fully paid parental leave
Commuter benefits
401k benefits
Fitness & home services stipend to cover part of your expenses so you can focus on what matters
A collaborative in-office environment with an open floor plan, fully stocked kitchen, and all meals covered in the office
Unlimited vacation and paid holidays
We'll cover relocation packages and make the move exciting, not painful!
Company
EliseAI
EliseAI is an AI-driven company that offers automation, streamlining workflows, and unique needs of housing and healthcare operations.
Funding
Current Stage
Late StageTotal Funding
$391.93MKey Investors
Andreessen HorowitzSapphire VenturesPoint72 Ventures
2025-08-19Series E· $250M
2024-08-14Series D· $75M
2023-06-06Series C· $35M
Recent News
Crunchbase News
2025-12-23
2025-12-21
Crunchbase News
2025-11-24
Company data provided by crunchbase